Kerry Hennessy is a Dermatology physician affiliated with University of South Florida. OpenAlex indexes 30 publications with 285 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Arcutis Biotherapeutics, Inc.Program year20257 payments
- Galderma Laboratories, L.P.Program year20256 payments
- ABBVIE INC.Program year20259 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
37.9%Azole Antifungal37.9%Ketoconazole100%Part D≥36 patientsRespiratory
25.8%RNA Synthetase Inhibitor Antibacterial25.8%Mupirocin100%Part D≥25 patientsDermatology
18.5%Corticosteroid18.5%Triamcinolone Acetonide100%Part D≥22 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Clinical characteristics and outcomes of melanoma and non-melanoma skin cancers in persons living with HIV
Archives of Dermatological Research
2026 - Dermatologic Conditions Following Limb Loss
Physical Medicine and Rehabilitation Clinics of North America
2024 - 50699 Pembrolizumab-Induced Lichenoid Drug Eruption Successfully Treated with Dupilumab – A Case Report
Journal of the American Academy of Dermatology
2024 - Aesthetic Considerations for Treating Lesbian, Gay, and Bisexual Patients: A Review and Our Experience.
PubMed
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Lockey, MD
University of South Florida
Robert Hauser, MD
University of South Florida
Charles Lockwood, MD
University of South Florida
Selim Benbadis, MD
University of South Florida
Robert Modlin, MD
University of California, Los Angeles
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Joel Gelfand, MD
University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”